RISK STRATIFICATION AND PATIENT COUNSELING FOR NATALIZUMAB IN MULTIPLE SCLEROSIS

被引：38
作者：
Fox, Robert J. [1 ]
Rudick, Richard A.
机构：
[1] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Dept Neurol, Cleveland, OH 44106 USA
来源：
NEUROLOGY | 2012年 / 78卷 / 06期
基金：
美国国家卫生研究院;
关键词：
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
D O I：
10.1212/WNL.0b013e318245d2d0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [1] Natalizumab: Risk Stratification of Individual Patients with Multiple Sclerosis
    Carmen Tur
    Xavier Montalban
    CNS Drugs, 2014, 28 : 641 - 648
  • [2] Natalizumab: Risk Stratification of Individual Patients with Multiple Sclerosis
    Tur, Carmen
    Montalban, Xavier
    CNS DRUGS, 2014, 28 (07) : 641 - 648
  • [3] Review on PML Risk Stratification in Natalizumab-Treated Multiple Sclerosis Patients
    Grigoriadis, Nikolaos C.
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 61 - 63
  • [4] Risk of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patient Treated With Natalizumab: A Systematic Review
    Vivekanandan, Govinathan
    Abubacker, Ansha P.
    Myneni, Revathi
    Chawla, Harsh, V
    Iqbal, Aimen
    Grewal, Amit
    Ndakotsu, Andrew
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [5] Risk stratification and mitigation in multiple sclerosis
    Ontaneda, Daniel
    Cohn, Samuel
    Fox, Robert J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (05) : 639 - 649
  • [6] NATALIZUMAB IN MULTIPLE SCLEROSIS
    Rio-Izquierdo, J.
    Montalban, X.
    REVISTA DE NEUROLOGIA, 2009, 49 (05) : 265 - 269
  • [7] Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
    Tur, Carmen
    Tintore, Mar
    Vidal-Jordana, Angela
    Bichuetti, Denis
    Nieto Gonzalez, Pablo
    Jesus Arevalo, Maria
    Arrambide, Georgina
    Anglada, Elisenda
    Galan, Ingrid
    Castillo, Joaquin
    Jordi Rio, Carlos Nos
    Isabel Martin, Maria
    Comabella, Manuel
    Sastre-Garriga, Jaume
    Montalban, Xavier
    PLOS ONE, 2013, 8 (12):
  • [8] Stratification of PML risk with natalizumab
    Reactions Weekly, 2012, 1404 (1) : 3 - 3
  • [9] Treating multiple sclerosis with natalizumab
    Iaffaldano, Pietro
    Lucchese, Guglielmo
    Trojano, Maria
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (12) : 1683 - 1692
  • [10] Natalizumab in the treatment of multiple sclerosis
    Horga, A.
    Horga de la Parte, J. F.
    REVISTA DE NEUROLOGIA, 2007, 45 (05) : 293 - 303
12345